513 related articles for article (PubMed ID: 23107633)
1. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
Kurbatova EV; Gammino VM; Bayona J; Becerra MC; Danilovitz M; Falzon D; Gelmanova I; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riekstina V; Taylor A; Viiklepp P; Zignol M; Cegielski JP
Int J Tuberc Lung Dis; 2012 Oct; 16(10):1335-43. PubMed ID: 23107633
[TBL] [Abstract][Full Text] [Related]
2. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
[TBL] [Abstract][Full Text] [Related]
3. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
Kliiman K; Altraja A
Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
[TBL] [Abstract][Full Text] [Related]
4. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
Lee J; Lee BJ; Yoon HI; Lee CT; Lee JH
Int J Tuberc Lung Dis; 2012 Oct; 16(10):1344-8. PubMed ID: 23107634
[TBL] [Abstract][Full Text] [Related]
5. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
Holtz TH; Sternberg M; Kammerer S; Laserson KF; Riekstina V; Zarovska E; Skripconoka V; Wells CD; Leimane V
Ann Intern Med; 2006 May; 144(9):650-9. PubMed ID: 16670134
[TBL] [Abstract][Full Text] [Related]
6. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
Shibabaw A; Gelaw B; Wang SH; Tessema B
PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
[TBL] [Abstract][Full Text] [Related]
7. Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.
Qi W; Harries AD; Hinderaker SG
Int J Tuberc Lung Dis; 2011 Jan; 15(1):137-9. PubMed ID: 21276311
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
[TBL] [Abstract][Full Text] [Related]
9. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
10. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
[TBL] [Abstract][Full Text] [Related]
11. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
Skenders GK; Holtz TH; Riekstina V; Leimane V
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1546-52, i. PubMed ID: 22008771
[TBL] [Abstract][Full Text] [Related]
12. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
[TBL] [Abstract][Full Text] [Related]
13. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.
Mendoza MT; Gonzaga AJ; Roa C; Velmonte MA; Jorge M; Montoya JC; Tan Torres T; Ong M; Barez MY; Ang CF
Int J Tuberc Lung Dis; 1997 Feb; 1(1):59-63. PubMed ID: 9441060
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting sputum smear conversion and treatment outcomes in new smear-positive pulmonary tuberculosis.
Unsematham S; Kateruttanakul P
J Med Assoc Thai; 2013 Jun; 96(6):644-9. PubMed ID: 23951819
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
16. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
Lee J; Lim HJ; Cho YJ; Park YS; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Yim JJ
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1331-3. PubMed ID: 22283890
[TBL] [Abstract][Full Text] [Related]
17. Identification of drug susceptibility pattern and mycobacterial species in sputum smear positive pulmonary tuberculosis patients with and without HIV co-infection in north west Ethiopia.
Mekonen M; Abate E; Aseffa A; Anagaw B; Elias D; Hailu E; Idh J; Moges F; Wolde-Amanuel Y; Asrat D; Yamuah L; Britton S; Stendahl O; Schön T
Ethiop Med J; 2010 Jul; 48(3):203-10. PubMed ID: 21073081
[TBL] [Abstract][Full Text] [Related]
18. Clofazimine in the treatment of multidrug-resistant tuberculosis.
Xu HB; Jiang RH; Xiao HP
Clin Microbiol Infect; 2012 Nov; 18(11):1104-10. PubMed ID: 22192631
[TBL] [Abstract][Full Text] [Related]
19. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
Aparna SB; Reddy VC; Gokhale S; Moorthy KV
Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
[TBL] [Abstract][Full Text] [Related]
20. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
Xu HB; Jiang RH; Li L; Xiao HP
Int J Tuberc Lung Dis; 2012; 16(3):358-63. PubMed ID: 22640450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]